GENNEX LABORATORIES LTD. - Board Meeting Outcome for Adoption Of Unaudited (Standalone & Consolidated) Financial Results For The Quarter Ended June 30, 2022

Download	< Back
12 Aug 2022
In just concluded Meeting of the Board Directors of the Company, the board has considered and approved: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2022 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2022 (annexed herewith). This intimation is also uploaded in the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
View all announcements for GENNEX LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us